Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1984 1
2001 3
2003 1
2004 1
2005 1
2006 2
2008 1
2009 1
2010 1
2011 2
2014 1
2019 2
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Who Let the Guards Out: Visual Support for Patrolling Games.
Lang M, Stepanek A, Zvara R, Rehak V, Kozlikova B. Lang M, et al. Among authors: rehak v. IEEE Trans Vis Comput Graph. 2025 Jan;31(1):34-43. doi: 10.1109/TVCG.2024.3456306. Epub 2024 Nov 25. IEEE Trans Vis Comput Graph. 2025. PMID: 39292569
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.
Zeuzem S, Sulkowski MS, Lawitz EJ, Rustgi VK, Rodriguez-Torres M, Bacon BR, Grigorescu M, Tice AD, Lurie Y, Cianciara J, Muir AJ, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-1 Study Team. Zeuzem S, et al. Gastroenterology. 2010 Oct;139(4):1257-66. doi: 10.1053/j.gastro.2010.06.066. Epub 2010 Jun 27. Gastroenterology. 2010. PMID: 20600013 Clinical Trial.
Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.
Husa P, Oltman M, Ivanovski L, Rehák V, Messinger D, Tietz A, Urbanek P. Husa P, et al. Among authors: rehak v. Eur J Gastroenterol Hepatol. 2011 May;23(5):375-81. doi: 10.1097/MEG.0b013e3283458407. Eur J Gastroenterol Hepatol. 2011. PMID: 21502923 Clinical Trial.
21 results